Stellate Ganglion Block for PTSD
A legfontosabb adatok
- Ki végzi
- VA Office of Research and Development
- Hol
- Long Beach, Madison, Minneapolis, Salt Lake City, Tampa és White River Junction (Egyesült Államok)Mind a 6 helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 410 fő vett részt
- Kezdés
- 2022. nov. 17.
- Befejezés
- 2026. jún. 30.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Stellate Ganglion Block
- Sham Stellate Ganglion Block
- A regiszteradat frissítve
- 2025. december 3.
Ki vehet részt
- Életkor
- 18 év – 80 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 23 feltétel megnézéseKevesebb
Ki vehet részt
- Veterans of any military branch
- DSM-5 criteria for chronic PTSD on the Clinician Administered PTSD Scale (CAPS-5)
- at least moderate PTSD with a total CAPS-5 score of > 26
- having had at least one trial of an evidence-based treatment (EBT) for PTSD; Verification of an EBT trial will be by:
- subject report of engaging in the EBT (whether it be psycho- or pharmaco-therapy)
- CPRS or other medical record system (if outside VA) verification to determine that the dose and time (applies to both meds and therapy) was an adequate trial OR that they clearly did not finish the EBT due to clear aversion; They will be eligible if they did not finish the EBT due to aversion, but they must have had a trial and be fully informed during informed consent for this study of the available clinical treatment options; Eligible persons may have other symptoms that are commonly comorbid with PTSD (e.g., anxiety, moderate depression); Severe primary depression will be an exclusion (see "Exclusion criteria" below); This strategy will provide a feasible and generalizable sample; Women and minorities will be recruited
Ki nem vehet részt
- thyroid disease and other contraindications to SGB (anatomic abnormalities of the anterior cervical spine; cardiac/pulmonary compromise; acute illness/infection; coagulopathy/bleeding disorder; allergic reactions/contraindications to local anesthetic or contrast dye, prior anterior neck surgery, anterior neck skin abnormalities (rash or eruptions))
- centrally acting medications that have a potential effect on biological expression
- pain levels requiring opiate medications
- past clear and chronic PTSD prior to military service
- current active psychotherapy for PTSD (they may suspend therapy if chosen by subject and therapist)
- having had any prior SGB
- unstable dose(s) of medication for depression, anxiety, PTSD, or for sleep, or any other psychoactive medication for 8-weeks prior to intervention
- unwillingness to continue active medications at the same doses for the duration of the trial; a person who is on a stable medication dose for > 8 weeks who meets inclusion criteria and will continue these medications for the trial duration will not be excluded
- decisional incapacity (e.g., dementia, clear evidence of testing that signifies incapacity to consent), OR Montreal Cognitive Assessment score <18
- a diagnosed and untreated moderate or severe sleep breathing disorder (SBD), OR a high risk of a SBD as indicated by snoring >50% of nights plus one of; any witnessed apnea; feeling non-refreshed in the morning >50% of mornings; daytime sleepiness indicated by falling asleep with routine tasks such as watching TV or reading
- clear current and past six-months psychosis clearly not related to PSTD hypervigilance,
- substance dependence (clear evidence of tolerance and/or withdrawal) within the past 6 months
- known exposure to chemicals or physical trauma that cause permanent neuropsychiatric sequelae
- severe depression (Quick Inventory of Depression-SR16 (QIDS-SR16 score >18) that is deemed more clinically significant than PTSD (i.e., depression, cluster D PTSD, and minimal symptoms from cluster B, C, and E)
- high risk of acute suicidality
- clear treatment non-adherence indicated by stopping treatment or >3 missed appointments in the course of at least three PTSD EBTs
- pregnancy
Helyszínek itt: Egyesült Államok
- VA Long Beach Healthcare System, Long Beach, CALong Beach, Egyesült Államok
- William S. Middleton Memorial Veterans Hospital, Madison, WIMadison, Egyesült Államok
- Minneapolis VA Health Care System, Minneapolis, MNMinneapolis, Egyesült Államok
- VA Salt Lake City Health Care System, Salt Lake City, UTSalt Lake City, Egyesült Államok
- James A. Haley Veterans' Hospital, Tampa, FLTampa, Egyesült Államok
- White River Junction VA Medical Center, White River Junction, VTWhite River Junction, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
Posttraumatic Stress Disorder (PTSD) is a debilitating condition that affects about 15% of Veterans. Current treatments for Veterans with PTSD include medications and psychological therapies that help to process and desensitize to traumatic events. While effective for many, these treatments do not work for all patients, and many may refuse them. Stellate Ganglion Block (SGB), established to treat pain and other conditions, has shown promise for PTSD: early small studies show it may work fast and greatly reduce symptoms. However, data from larger studies are not clear about SGBs effects. A definitive trial is needed, especially for the Veteran population. This large, well-powered, randomized, sham-controlled trial of SGB for PTSD will assess the short-term efficacy of this intervention, the durability of the effects and the safety of the treatment. Additionally, this study will provide critically important information about biological effects of SGB and potential mechanisms of action. This timely study is critical to help VA clinicians better decide about the merits of SGB for PTSD.
A vizsgálat 3 csoportja
- SGBMár használt kezelés, összehasonlításként
SGB, the experimental procedure, is the injection of 7 cc of 0.5% ropivacaine plus 0.5 cc contrast anterior to the prevertebral fascia at the ventral aspect of the longus colli muscle, medial to Chassaignac's tubercle
Kezelés: Stellate Ganglion Block
- ShamSzínlelt kezelés, összehasonlításként
Sham, the placebo control group, is the injection of 7 cc of normal saline plus 0.5 cc contrast anterior to the prevertebral fascia at the ventral aspect of the longus colli muscle, medial to Chassaignac's tubercle
Kezelés: Sham Stellate Ganglion Block
- Wait-List Control (WLC)Nincs vizsgálati kezelés, összehasonlításként
WLC, a control for time, expectancy and safety, is all study procedures without going to the procedure room for injection
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Efficacy and Safety of Stellate Ganglion Block for Post-traumatic Stress Disorder in Veterans
- Publikációk
- A regiszteradat frissítve
- 2025. december 3.